Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SGRY
SGRY logo

SGRY Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
17.330
Open
17.090
VWAP
17.13
Vol
1.29M
Mkt Cap
2.25B
Low
16.890
Amount
22.17M
EV/EBITDA(TTM)
11.21
Total Shares
130.79M
EV
7.55B
EV/OCF(TTM)
26.96
P/S(TTM)
0.65
Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The Company operates through the Surgical Facility segment, which includes the operation of ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. The Company operates a portfolio of approximately 162 surgical facilities comprised of 175 ASCs and 19 surgical hospitals. The Company is focused on surgical services businesses in the United States, with over 200 locations in 30 states, including short-stay surgical hospitals.
Show More

Events Timeline

(ET)
2026-05-05
16:40:00
Major U.S. Averages Close Broadly Higher, Nasdaq Up 1.03%
select
2026-05-05
12:10:00
Major Averages Broadly Higher, Nasdaq Up 1%
select
2026-05-05
08:10:00
Company Reports Q1 Revenue of $810.9M, Beating Expectations
select
2026-05-05
08:10:00
Company Reaffirms FY26 Adjusted EBITDA View at Least $530M
select

News

NASDAQ.COM
8.5
07-03NASDAQ.COM
Ensign Group Acquires Texas Nursing Facilities to Expand Operations
  • Market Expansion: Ensign Group completed the acquisition of two nursing facilities in Texas on July 1, 2026, adding 250 licensed beds and expanding its network to 398 healthcare operations, thereby solidifying its position in a rapidly growing market.
  • Enhanced Financial Flexibility: The transaction was executed by its real estate subsidiary, Standard Bearer Healthcare REIT, which maintains the independence of real estate assets, enhancing financial flexibility and operational control to support long-term growth.
  • Return on Investment: Ensign's return on invested capital (ROIC) stands at 8.12%, significantly above the industry average of 3.05%, demonstrating the effectiveness of its acquisition strategy and is expected to further drive profitability.
  • Strategic Alignment: This acquisition aligns with Ensign's long-term expansion strategy, leveraging a decentralized operating model to improve care quality and occupancy rates, which is anticipated to create sustained value for shareholders.
Yahoo Finance
2.0
07-03Yahoo Finance
Surgery Partners Stock Rises 2.7% Following Analyst Upgrade
  • Analyst Rating Reaffirmed: Cantor Fitzgerald reiterated its 'Overweight' rating on Surgery Partners (SGRY) with an $18.00 price target, leading to a 2.7% increase in stock price during the morning session, indicating market confidence in the company's future prospects.
  • Optimistic Profit Outlook: Despite slight negative trends in second-quarter outpatient surgery center and nursing data, analysts predict the company will be profitable this year, with net income expected to grow, reflecting recognition of the company's operational capabilities.
  • Stock Volatility Analysis: Over the past year, Surgery Partners' shares have experienced 11 moves greater than 5%, and today's increase suggests that the market considers this news significant, although it does not fundamentally alter perceptions of the business.
  • Long-term Investment Returns: Although the stock has risen 12.4% year-to-date, the current price of $17.15 is still 28.1% below its 52-week high of $23.84, indicating that investors who bought shares five years ago would have seen a return of only $262.50 on a $1,000 investment.
Fool
7.5
06-10Fool
Healthcare Shift: Outpatient vs. Home Care Specialists
  • Surgical Solutions Network: Surgery Partners operates over 300 surgical centers across 30 states, generating more than $3.3 billion in revenue for FY 2025, a 6% increase despite a net loss of $77.9 million, highlighting its strategic focus on expanding market share.
  • Home Care Growth: Viemed Healthcare specializes in home-based respiratory care, achieving approximately $270.3 million in revenue for FY 2025, a 21% increase, with a net income of $14.9 million, indicating its success in addressing the needs of the aging population and chronic disease patients.
  • Financial Structure Comparison: Surgery Partners has a debt-to-equity ratio of 2.3x, indicating significant reliance on borrowed funds, while Viemed's ratio is only 0.1x, reflecting a conservative financial structure that aids flexibility during economic fluctuations.
  • Market Outlook Analysis: As insurance companies favor home care to reduce hospital costs, Viemed's revenue surged over 28% year-over-year in Q1 2026, with full-year growth projected at 17%, while Surgery Partners is expected to see only a 3% revenue increase.
NASDAQ.COM
7.5
06-10NASDAQ.COM
Investment Comparison: Surgery Partners vs. Viemed Healthcare
  • Market Positioning: Surgery Partners operates over 300 surgical centers nationwide, generating over $3.3 billion in FY 2025 revenue, which grew by 6% despite a net loss of $77.9 million, indicating the short-term costs of its expansion strategy.
  • Financial Structure Comparison: Viemed Healthcare focuses on home-based respiratory care, achieving approximately $270.3 million in FY 2025 revenue, a 21% increase, with a net income of $14.9 million, showcasing its profitability and robust financial structure in a high-demand niche.
  • Regulatory Risk Assessment: Surgery Partners faces compliance risks from federal laws, with about $3.7 billion in debt potentially limiting its ability to respond to economic shifts, while Viemed Healthcare's reliance on Medicare reimbursement means policy changes can directly impact its revenue.
  • Future Growth Potential: Viemed Healthcare's revenue surged over 28% year-over-year in Q1 2026, with an expected annual growth of 17%, while Surgery Partners anticipates only a 3% revenue increase, highlighting Viemed's strong growth momentum in the home care market.
seekingalpha
9.5
05-05seekingalpha
Surgery Partners Q1 2026 Earnings Call Insights
  • Stable Revenue Performance: In Q1 2026, Surgery Partners reported approximately $811 million in net revenue with a 4.4% year-over-year growth, indicating a gradual recovery and stabilization of operations following pressures experienced at the end of 2025.
  • EBITDA and Margin: The adjusted EBITDA for the quarter was $102 million, resulting in an EBITDA margin of 12.6%, aligning with expectations for the seasonally lower first quarter, which reflects progress in cost management and operational efficiency.
  • Investment in Surgical Robots: The company operates 73 surgical robots, contributing to a 14.6% year-over-year growth in total joints performed, which not only enhances service capabilities but also strengthens its competitive position in a challenging market.
  • Future Outlook and Acquisition Plans: Management reiterated full-year 2026 revenue guidance of $3.35 billion to $3.45 billion while actively pursuing a key acquisition opportunity in a larger surgical hospital market, expected to be announced in mid-2026, demonstrating confidence in future growth prospects.
NASDAQ.COM
2.0
05-05NASDAQ.COM
Surgery Partners SGRY Q1 2026 Earnings Transcript
Wall Street analysts forecast SGRY stock price to rise
11 Analyst Rating
Wall Street analysts forecast SGRY stock price to rise
8 Buy
3 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
18.00
Averages
26.30
High
36.00
Current: 0.000
sliders
Low
18.00
Averages
26.30
High
36.00
Jefferies
Buy
maintain
$15 -> $17
AI Analysis
2026-05-06
Reason
Jefferies
Price Target
$15 -> $17
AI Analysis
2026-05-06
maintain
Buy
Reason
Jefferies raised the firm's price target on Surgery Partners to $17 from $15 and keeps a Buy rating on the shares. The firm says the company had a good Q1, particularly given the weather-related headwinds that affected most health-care services providers. Payor mix issues that emerged last quarter moderated in Q1 and should gradually improve over the course of the year, Jefferies argues.
Jefferies
Buy
downgrade
$15
2026-04-20
Reason
Jefferies
Price Target
$15
2026-04-20
downgrade
Buy
Reason
Jefferies lowered the firm's price target on Surgery Partners to $15 from $16.25 and keeps a Buy rating on the shares. The relative underperformance of healthcare services stocks highlights concerns among investors about Q1 volumes, notes the analyst, who is "unsure if Street numbers adequately reflect" drags from ice storms in Southern states and snow storms in the East Coast that impacted volumes.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SGRY
Unlock Now

Valuation Metrics

The current forward P/E ratio for Surgery Partners Inc (SGRY.O) is 24.94, compared to its 5-year average forward P/E of -264.85. For a more detailed relative valuation and DCF analysis to assess Surgery Partners Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-264.85
Current PE
24.94
Overvalued PE
1274.09
Undervalued PE
-1803.80

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
16.48
Current EV/EBITDA
11.08
Overvalued EV/EBITDA
20.86
Undervalued EV/EBITDA
12.09

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.16
Current PS
0.63
Overvalued PS
1.57
Undervalued PS
0.75

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

stocks bullish for the next three months
Intellectia · 83 candidates
Region: USRelative Vol: >= 1.50Moving Average Relationship: PriceAboveMA20, PriceAboveMA60One Week Predict Return: >= 0.0%One Month Rise Prob: >= 50One Month Predict Return: >= 0.0%Macd: bullish, positive
Ticker
Name
Market Cap$
top bottom
GSBD logo
GSBD
Goldman Sachs BDC Inc
1.14B
MRAM logo
MRAM
Everspin Technologies Inc
503.89M
MTRX logo
MTRX
Matrix Service Co
380.30M
AUDC logo
AUDC
AudioCodes Ltd
263.27M
GTX logo
GTX
Garrett Motion Inc
4.84B
BRAG logo
BRAG
Bragg Gaming Group Inc
51.66M
market movers ready to brakeout
Intellectia · 14 candidates
Rsi Category: moderateRelative Vol: >= 1.80Week Price Change Pct: $3.00 - $15.00Support Resistance Relationship: PriceAroundResistance, PriceAroundUpperBollMonthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
NTLA logo
NTLA
Intellia Therapeutics Inc
1.82B
POET logo
POET
POET Technologies Inc
1.06B
NTR logo
NTR
Nutrien Ltd
36.44B
AMBP logo
AMBP
Ardagh Metal Packaging SA
2.90B
SGRY logo
SGRY
Surgery Partners Inc
2.05B
ALMU logo
ALMU
Aeluma Inc
347.27M
create a small cap screener
Intellectia · 1387 candidates
Market Cap Category: small
Ticker
Name
Market Cap$
top bottom
SGRY logo
SGRY
Surgery Partners Inc
2.00B
QDEL logo
QDEL
QuidelOrtho Corp
2.00B
NESR logo
NESR
National Energy Services Reunited Corp
2.00B
DXPE logo
DXPE
DXP Enterprises Inc
2.00B
SKWD logo
SKWD
Skyward Specialty Insurance Group Inc
2.00B
NTCT logo
NTCT
Netscout Systems Inc
2.00B
small cap stocks $20 and under
Intellectia · 870 candidates
Price: <= $20.00Market Cap Category: small
Ticker
Name
Market Cap$
top bottom
NESR logo
NESR
National Energy Services Reunited Corp
2.00B
SGRY logo
SGRY
Surgery Partners Inc
2.00B
FMC logo
FMC
FMC Corp
1.99B
HLMN logo
HLMN
Hillman Solutions Corp
1.96B
SBET logo
SBET
SharpLink Gaming Inc
1.96B
RNW logo
RNW
Renew Energy Global PLC
1.95B

Whales Holding SGRY

G
Glenview Capital Management, LLC
Holding
SGRY
+16.05%
3M Return
D
Davidson Kempner Capital Management LP
Holding
SGRY
+8.38%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Surgery Partners Inc (SGRY) stock price today?

The current price of SGRY is 17.17 USD — it has increased 1

What is Surgery Partners Inc (SGRY)'s business?

Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The Company operates through the Surgical Facility segment, which includes the operation of ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. The Company operates a portfolio of approximately 162 surgical facilities comprised of 175 ASCs and 19 surgical hospitals. The Company is focused on surgical services businesses in the United States, with over 200 locations in 30 states, including short-stay surgical hospitals.

What is the price predicton of SGRY Stock?

Wall Street analysts forecast SGRY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SGRY is26.30 USD with a low forecast of 18.00 USD and a high forecast of 36.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Surgery Partners Inc (SGRY)'s revenue for the last quarter?

Surgery Partners Inc revenue for the last quarter amounts to 810.90M USD, increased 4.50

What is Surgery Partners Inc (SGRY)'s earnings per share (EPS) for the last quarter?

Surgery Partners Inc. EPS for the last quarter amounts to -0.28 USD, decreased -6.67

How many employees does Surgery Partners Inc (SGRY). have?

Surgery Partners Inc (SGRY) has 16000 emplpoyees as of July 08 2026.

What is Surgery Partners Inc (SGRY) market cap?

Today SGRY has the market capitalization of 2.25B USD.